pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 19·1 min read
save

UK adopts tobacco-free generation law, mirroring Massachusetts policy

May 19, 2026·read at STAT ↗RegulatoryPositive

The United Kingdom has passed a tobacco‑free generation law that bars retailers from selling cigarettes, vapes or nicotine pouches to anyone born on or after Jan. 1, 2009. Existing customers may continue to purchase, but the birth‑date cutoff creates a permanent sales ban for the next generation.

The measure follows a similar approach in Massachusetts, where 24 municipalities have implemented a "nicotine free generation" policy covering about 659,000 residents. Brookline was the first to adopt the rule in 2021, and the state Supreme Judicial Court upheld the policy against retailer challenges in 2024.

By adopting the law, the UK adds roughly 69 million people to the protected cohort, extending the public‑health experiment that began in the U.S. The authors argue that such policies should persist despite pushback from the tobacco industry.

The article notes that Massachusetts is now debating whether to expand or modify its own birth‑date phaseout, highlighting ongoing debate over the approach.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Britain embraces a Massachusetts experiment on tobacco regulation — just as the state might roll it back”

read at STAT ↗
1,167 words · retrieved May 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2
drugs
nicotine6nicotine ER6
topics
Pulmonology3Vaccine2AdComApprovalCardiology

related stories

  • 20h agoCaribou to stop R&D work, start ‘substantial’ job cutsBioSpace
  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 28Juul gets OK to sell updated vaping device with age-gating technologySTAT
  • Aug 27RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute thatSTAT
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT